Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the effectiveness of adding etanercept to disease
modifying anti-rheumatic drug (DMARD) therapy in patients with moderately active Rheumatoid
Arthritis (RA).